SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals
REGN 755.75+2.5%Nov 21 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: juneau_boy who wrote (435)5/2/2000 10:56:00 PM
From: Miljenko Zuanic  Read Replies (2) of 3559
 
<<And another.....what is the timeline and potential of BDNF?>>

Results from ongoing trials should start coming by year end. Regards the potential, your guess is as good as my. I do believe that BDNF utility will be more than simple ALS population, the some opinion have Sumitomo.

However, based on increased short position for last month, some investors do not think some. This may be part of the price stabilization (read deflation, by certain underwriters) before secondary. Soon or later they will cover their positions.

Miljenko
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News